Shionogi & Co., Ltd. (SGIOY)

Market Cap	18.68B +44.4%
Revenue (ttm)	2.97B +1.9%
Net Income	1.24B +15.5%
EPS	1.46 +15.7%
Shares Out	n/a
PE Ratio	15.04
Forward PE	n/a
Dividend	0.43 (4.01%)
Ex-Dividend Date	Mar 30, 2026

Volume	58,684
Average Volume	98,174
Open	10.47
Previous Close	10.65
Day's Range	10.47 - 10.82
52-Week Range	7.27 - 12.00
Beta	0.02
RSI	47.72
Earnings Date	May 8, 2026

About Shionogi &

Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. The company was founded in 1878 and is headquartered in Osaka, Japan.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1878
• Employees: 4,955
• Stock Exchange: OTCMKTS
• Ticker Symbol: SGIOY

Financial Performance

In fiscal year 2025, Shionogi &'s revenue was 438.27 billion, an increase of 0.73% compared to the previous year's 435.08 billion. Earnings were 170.44 billion, an increase of 5.19%.

Financial numbers in JPY